$MASI
MASIMO CORP Stock $masi

$masi Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000093755615000155 Filed on November 06, 2015

Income Statement

Concept	2015 Q4	2015 Q1	2014 Q3
Revenue	$152.6M	$161.8M	$144.1M
YoY Change		15.73%	9.64%
Cost Of Revenue	$50.34M	$52.60M	$47.89M
YoY Change		10.71%	8.93%
Gross Profit	$102.2M	$109.2M	$96.22M
YoY Change		18.31%	10.0%
Gross Profit Margin	67.0%	67.49%	66.77%
Selling, General & Admin	$59.61M	$61.50M	$62.06M
YoY Change		9.58%	16.9%
% of Gross Profit	58.31%	56.32%	64.5%
Research & Development	$14.49M	$15.00M	$14.21M
YoY Change		7.17%	4.16%
% of Gross Profit	14.17%	13.74%	14.77%
Depreciation & Amortization	$3.900M	$3.300M	$3.400M
YoY Change		8.45%	17.24%
% of Gross Profit	3.81%	3.02%	3.53%
Operating Expenses	$74.09M	$76.50M	$73.96M
YoY Change		23.17%	10.82%
Operating Profit	$28.14M	$32.70M	$22.27M
YoY Change		8.3%	7.35%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.050M	-$1.400M	-$566.0K
YoY Change		-800.0%	-16.27%
Pretax Income	$27.09M	$31.20M	$21.70M
YoY Change		2.66%	8.15%
Income Tax	$9.161M	$9.400M	$5.568M
% Of Pretax Income	33.82%	30.13%	25.66%
Net Earnings	$19.33M	$21.20M	$14.86M
YoY Change		-99.91%	-4.74%
Net Earnings / Revenue	12.67%	13.1%	10.31%
Basic Earnings Per Share	$0.38		$0.28
Diluted Earnings Per Share	$0.36	$399.2K	$0.27
COMMON SHARES
Basic Shares Outstanding	50.97M shares	52.61M shares	53.99M shares
Diluted Shares Outstanding	53.69M shares		54.62M shares

Balance Sheet

Concept	2015 Q4	2015 Q1	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.6M	$134.5M	$119.0M
YoY Change		14.47%	29.77%
Cash & Equivalents	$103.6M	$134.5M	$119.0M
Short-Term Investments
Other Short-Term Assets	$37.21M	$21.47M	$5.429M
YoY Change		438.66%	85.42%
Inventory	$73.31M	$69.72M	$62.83M
Prepaid Expenses	$10.36M	$9.816M	$11.22M
Receivables	$75.47M	$71.02M	$73.24M
Other Receivables	$7.300M	$7.600M	$6.800M
Total Short-Term Assets	$297.5M	$297.1M	$299.6M
YoY Change		3.63%	14.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$128.6M	$102.0M	$87.62M
YoY Change		300.03%	251.39%
Goodwill	$20.45M	$20.98M	$21.75M
YoY Change		-8.18%	-5.26%
Intangibles	$27.88M	$27.77M	$28.19M
YoY Change		-1.41%	0.55%
Long-Term Investments
YoY Change
Other Assets	$11.32M	$7.485M	$7.552M
YoY Change		-12.12%	5.03%
Total Long-Term Assets	$280.2M	$267.9M	$232.8M
YoY Change		55.8%	40.41%
TOTAL ASSETS
Total Short-Term Assets	$297.5M	$297.1M	$299.6M
Total Long-Term Assets	$280.2M	$267.9M	$232.8M
Total Assets	$577.8M	$565.0M	$532.5M
YoY Change		23.19%	24.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.74M	$38.05M	$28.99M
YoY Change		12.94%	-23.98%
Accrued Expenses	$24.10M	$24.54M	$31.51M
YoY Change		49.2%	97.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K	$100.0K	$125.1M
YoY Change		0.0%	125000.0%
Total Short-Term Liabilities	$111.8M	$123.9M	$240.2M
YoY Change		27.81%	132.3%
LONG-TERM LIABILITIES
Long-Term Debt	$190.1M	$125.1M	$100.0K
YoY Change		62450.0%	-50.0%
Other Long-Term Liabilities	$7.342M	$7.773M	$7.544M
YoY Change		2.95%	-22.09%
Total Long-Term Liabilities	$7.342M	$7.773M	$7.544M
YoY Change		2.95%	-22.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$111.8M	$123.9M	$240.2M
Total Long-Term Liabilities	$7.342M	$7.773M	$7.544M
Total Liabilities	$309.6M	$257.3M	$248.4M
YoY Change		144.53%	118.11%
SHAREHOLDERS EQUITY
Retained Earnings	$264.5M	$205.3M	$184.0M
YoY Change		32.11%	49.11%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$316.1M	$185.9M	$185.3M
YoY Change		122.76%	122.07%
Treasury Stock Shares	12.16M shares	8.611M shares	8.583M shares
Shareholders Equity	$269.2M	$306.0M	$282.9M
YoY Change
Total Liabilities & Shareholders Equity	$577.8M	$565.0M	$532.5M
YoY Change		23.19%	24.48%

Cashflow Statement

Concept	2015 Q4	2015 Q1	2014 Q3
OPERATING ACTIVITIES
Net Income	$19.33M	$21.20M	$14.86M
YoY Change		-99.91%	-4.74%
Depreciation, Depletion And Amortization	$3.900M	$3.300M	$3.400M
YoY Change		8.45%	17.24%
Cash From Operating Activities	$27.10M	$28.80M	$28.00M
YoY Change		18.88%	77.22%
INVESTING ACTIVITIES
Capital Expenditures	-$16.70M	-$9.400M	-$5.600M
YoY Change		-408.7%	47.37%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$16.70M	-$9.400M	-$5.600M
YoY Change		139.12%	47.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.20M	-2.100M	800.0K
YoY Change		-214.75%	33.33%
NET CHANGE
Cash From Operating Activities	27.10M	28.80M	28.00M
Cash From Investing Activities	-16.70M	-9.400M	-5.600M
Cash From Financing Activities	-26.20M	-2.100M	800.0K
Net Change In Cash	-15.80M	17.30M	23.20M
YoY Change		-21.81%	84.13%
FREE CASH FLOW
Cash From Operating Activities	$27.10M	$28.80M	$28.00M
Capital Expenditures	-$16.70M	-$9.400M	-$5.600M
Free Cash Flow	$43.80M	$38.20M	$33.60M
YoY Change		80.35%	71.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-02
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-10-03
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000937556
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50287697	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MASIMO CORP
	dei	Trading Symbol TradingSymbol	MASI
CY2015Q1	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	11645000	USD
CY2015Q4	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	11912000	USD
	masi	Cash Equivalents Maximum Maturity Period CashEquivalentsMaximumMaturityPeriod	Three months or less
CY2015Q1	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
CY2015Q4	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1500000	shares
	masi	Initial Term Of Executive Employment Agreement InitialTermOfExecutiveEmploymentAgreement	P3Y
	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.14
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2700000	USD
CY2015Q1	masi	Concentration Risk Net Assets Geographic Area Percentage ConcentrationRiskNetAssetsGeographicAreaPercentage	1.000
CY2015Q4	masi	Concentration Risk Net Assets Geographic Area Percentage ConcentrationRiskNetAssetsGeographicAreaPercentage	1.000
	masi	Income Tax Benefit From Exercise Of Stock Options Granted IncomeTaxBenefitFromExerciseOfStockOptionsGranted	49000	USD
	masi	Income Tax Benefit From Exercise Of Stock Options Granted IncomeTaxBenefitFromExerciseOfStockOptionsGranted	2006000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2013Q4	masi	License Fee Aggregate LicenseFeeAggregate	2500000	USD
CY2014Q3	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.12
	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.11
CY2015Q4	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.12
	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.12
CY2013Q4	masi	License Fees Individual LicenseFeesIndividual	500000	USD
	masi	Long Term Sales Agreement Warranty Maximum LongTermSalesAgreementWarrantyMaximum	P7Y
	masi	Long Term Sales Agreement Warranty Minimum LongTermSalesAgreementWarrantyMinimum	P3Y
CY2011Q3	masi	Numberof Former Sales Representatives NumberofFormerSalesRepresentatives	2	sales_representatives
CY2014Q1	masi	Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial	2	participant
	masi	Numberof Sourcesof Product Revenue NumberofSourcesofProductRevenue	4	segment
CY2015Q3	masi	Patentand Licensing Fee Aggregate PatentandLicensingFeeAggregate	2400000	USD
CY2014Q3	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.14
CY2015Q4	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.15
	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.15
CY2015Q2	masi	Property Plantand Equipment Numberof Square Feet Purchased PropertyPlantandEquipmentNumberofSquareFeetPurchased	90000	sqft
CY2015Q3	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	78000	sqft
CY2014Q3	masi	Royalty Royalty	6976000	USD
	masi	Royalty Royalty	21988000	USD
CY2015Q4	masi	Royalty Royalty	7972000	USD
	masi	Royalty Royalty	23266000	USD
	masi	Royalty Rate Percentage RoyaltyRatePercentage	0.0775
CY2015Q1	masi	Royalty Receivable RoyaltyReceivable	7200000	USD
CY2015Q4	masi	Royalty Receivable RoyaltyReceivable	7000000	USD
	masi	Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd	P60D
CY2015Q4	masi	Severance Plan Participation Agreements SeverancePlanParticipationAgreements	7	Agreement
CY2014Q4	masi	Stock Repurchase Program Numberof Additional Shares Authorizedinthe Period StockRepurchaseProgramNumberofAdditionalSharesAuthorizedinthePeriod	3000000	shares
	masi	Stockrepurchasedunsettledatperiodend Stockrepurchasedunsettledatperiodend	3196000	USD
	masi	Stockrepurchasedunsettledatperiodend Stockrepurchasedunsettledatperiodend	0	USD
	masi	Supplemental Unemployment Benefits Severance Benefits Required Noticeof Resignation SupplementalUnemploymentBenefitsSeveranceBenefitsRequiredNoticeofResignation	P6M
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	38045000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28735000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	71017000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75465000	USD
CY2015Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	4372000	USD
CY2015Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	3648000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6562000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2481000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24541000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24096000	USD
CY2015Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	400000	USD
CY2015Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	200000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	57084000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62603000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2093000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-4339000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288686000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	325128000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2180000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	USD
CY2015Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7784000	USD
CY2015Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2703000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8132000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1890000	USD
CY2015Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3100000	shares
CY2015Q1	us-gaap	Assets Assets	565006000	USD
CY2015Q4	us-gaap	Assets Assets	577786000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	315141000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	297549000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3330000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7093000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	36000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	145000	USD
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	100000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	193000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	8000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	8000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	82000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	88000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	3000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	4000	USD
CY2015Q1	us-gaap	Cash Cash	92900000	USD
CY2015Q4	us-gaap	Cash Cash	84900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95466000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118988000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134453000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103581000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23522000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-30872000	USD
CY2015Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	41600000	USD
CY2015Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	18700000	USD
CY2015Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	2300000	USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9481000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-74000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13162000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	47886000	USD
CY2015Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19437000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56953000	USD
CY2015Q1	us-gaap	Concentration Risk Net Assets Amount Geographic Area ConcentrationRiskNetAssetsAmountGeographicArea	307741000	USD
CY2015Q4	us-gaap	Concentration Risk Net Assets Amount Geographic Area ConcentrationRiskNetAssetsAmountGeographicArea	268234000	USD
CY2014Q3	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2015Q4	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52594000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50287000	shares
CY2015Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52000	USD
CY2015Q4	us-gaap	Contractual Obligation ContractualObligation	13533000	USD
CY2015Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	1036000	USD
CY2015Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	2299000	USD
CY2015Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	2722000	USD
CY2015Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	3402000	USD
CY2015Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	3012000	USD
CY2015Q4	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	1062000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	47894000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	143236000	USD
CY2015Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	50343000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	154600000	USD
	us-gaap	Debt Issuance Costs DebtIssuanceCosts	-143000	USD
	us-gaap	Debt Issuance Costs DebtIssuanceCosts	0	USD
CY2015Q1	us-gaap	Deferred Costs DeferredCosts	67485000	USD
CY2015Q4	us-gaap	Deferred Costs DeferredCosts	67891000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2926000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	21067000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	24647000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	453000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	337000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	18065000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	18062000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	24193000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	24124000	USD
CY2014Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	600000	USD
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1800000	USD
CY2015Q4	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	600000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1837000	USD
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1800000	USD
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
	us-gaap	Depreciation Depreciation	6800000	USD
	us-gaap	Depreciation Depreciation	8600000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2326000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1835000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33600000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	31734000	USD
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	23300000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P5Y9M18D
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-74000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1837000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11603000	USD
CY2015Q1	us-gaap	Due From Employees Current DueFromEmployeesCurrent	385000	USD
CY2015Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	320000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13015000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15800000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	12717000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3596000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2458000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2592000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3156000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3364000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	40786000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43683000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27771000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27883000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	20979000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	20452000	USD
CY2014Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2015Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	96224000	USD
	us-gaap	Gross Profit GrossProfit	281620000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	102232000	USD
	us-gaap	Gross Profit GrossProfit	308238000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	21702000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	70823000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4000000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27090000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	81336000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5568000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18246000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9161000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24889000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	15110000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	29854000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1609000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4179000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3198000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5048000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	558000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2212000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5446000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-276000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	3580000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	528000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	445000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3465000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1181000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1436000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6306000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3755000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4793000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4140000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-136000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-272000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	685000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	5003000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	630000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	860000	shares
CY2015Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2712000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2293000	shares
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27771000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27883000	USD
	us-gaap	Interest Paid Net InterestPaidNet	222000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1548000	USD
CY2015Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	30642000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	35914000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	69718000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	73311000	USD
CY2015Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	33056000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	32831000	USD
CY2015Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6020000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4566000	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1600000	USD
CY2015Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1200000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
	us-gaap	Product Warranty Expense ProductWarrantyExpense	828000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	190100000	USD
CY2015Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	79000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	80000	USD
CY2014Q1	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	-8000000	USD
CY2014Q3	us-gaap	Legal Fees LegalFees	-2321000	USD
	us-gaap	Legal Fees LegalFees	-10331000	USD
CY2015Q4	us-gaap	Legal Fees LegalFees	0	USD
	us-gaap	Legal Fees LegalFees	0	USD
CY2015Q1	us-gaap	Liabilities Liabilities	257265000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	309552000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	565006000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	577786000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	123894000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	111773000	USD
CY2014Q4	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	466800000	USD
CY2015Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	125145000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	1742000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	-1001000	USD
CY2015Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	1100000	USD
CY2015Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	1200000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28651000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-38927000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69626000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43605000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	66823000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	53495000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	14863000	USD
	us-gaap	Net Income Loss NetIncomeLoss	51297000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	19325000	USD
	us-gaap	Net Income Loss NetIncomeLoss	59199000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1271000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1280000	USD
CY2015Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1396000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2752000	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	9000	USD
CY2015Q1	us-gaap	Noncurrent Assets NoncurrentAssets	197209000	USD
CY2015Q4	us-gaap	Noncurrent Assets NoncurrentAssets	224343000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-566000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1050000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2022000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	73956000	USD
	us-gaap	Operating Expenses OperatingExpenses	210754000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	74092000	USD
	us-gaap	Operating Expenses OperatingExpenses	224880000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	22268000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	70866000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	83358000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	13340000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	28140000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2291000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2714000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2930000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3314000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1033000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1058000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7108000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7321000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	21471000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21710000	USD
CY2015Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4070000	USD
CY2015Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4029000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7485000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11318000	USD
CY2015Q4	us-gaap	Other Commitment OtherCommitment	300000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1701000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3411000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	112000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2246000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14433000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	49166000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18041000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	54201000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7773000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7342000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	98676000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	130157000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	472000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2779000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3085000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66847000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40520000	USD
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9816000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10361000	USD
CY2015Q1	us-gaap	Prepaid Taxes PrepaidTaxes	417000	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	5420000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-38000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	4000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	125000000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	107500000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2687000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	24942000	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1161000	USD
CY2014Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1058000	USD
CY2015Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1416000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1215000	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	684000	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	679000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	25000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-52000	USD
	us-gaap	Product Warranty Expense ProductWarrantyExpense	812000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	16134000	USD
	us-gaap	Profit Loss ProfitLoss	52577000	USD
CY2015Q4	us-gaap	Profit Loss ProfitLoss	17929000	USD
	us-gaap	Profit Loss ProfitLoss	56447000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	8500000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	159036000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	191172000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101952000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128569000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	28300000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	211000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	506000	USD
CY2015Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	85500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	42500000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	105000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	81000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14213000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41552000	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14485000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42808000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	205260000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	264459000	USD
CY2014Q3	us-gaap	Revenues Revenues	144118000	USD
	us-gaap	Revenues Revenues	424856000	USD
CY2015Q4	us-gaap	Revenues Revenues	152575000	USD
	us-gaap	Revenues Revenues	462838000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	137142000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.331
CY2015Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59607000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	182072000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	402868000	USD
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	144603000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	439572000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	179533000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62064000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation ShareBasedCompensation	7784000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8132000	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.356
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.374
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.321
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.317
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.317
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5188000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.323
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.320
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.016
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.014
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.015
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.85
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.82
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	52500000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9956000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5524000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.62
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	21600000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	196000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	781000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.79
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9289000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.59
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.04
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	22500000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.92
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.51
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	35.28
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M6D
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M12D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1252000	shares
CY2015Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000.0	shares
CY2013Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	6000000.0	shares
CY2014Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	9000000.0	shares
CY2015Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000.0	shares
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	305999000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	269235000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	307741000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	268234000	USD
CY2015Q1	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	40500000	USD
CY2015Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	17500000	USD
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	21.95
CY2015Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	41.44
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	36.71
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	8611000	shares
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	12156000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2400000	shares
CY2015Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1200000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3500000	shares
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	185906000	USD
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	316063000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	52700000	USD
CY2015Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	48500000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	130200000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8700000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7100000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54618000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56381000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53686000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53946000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53988000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55521000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50974000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51653000	shares
	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 fiscal year, a 52 week fiscal year includes four quarters of 13 fiscal weeks while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. The Company’s last 53 week fiscal year was fiscal year 2014. Fiscal year 2015 is a 52 week fiscal year. All references to years in these notes to condensed consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (the Company) is a global medical technology company that develops, manufactures and markets a variety of noninvasive patient monitoring technologies. The Company’s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications. The Company’s patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use, reusable or resposable sensors, software and/or cables. The Company primarily sells its products to hospitals, emergency medical service (EMS) providers, home care providers, physician offices, veterinarians, long term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invented Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">® </sup></font><font style="font-family:inherit;font-size:10pt;">(SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), which provides the capabilities of Measure-Through-Motion and Low-Perfusion</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> pulse oximetry to address the primary limitations of conventional pulse oximetry. Over the years, the Company’s product offerings have expanded significantly to also include noninvasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. The Company also developed the Root</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> patient monitoring and connectivity platform and the Masimo Patient SafetyNet</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> remote patient surveillance monitoring system. These solutions and related products are based upon Masimo SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and other proprietary algorithms. These software-based technologies are incorporated into a variety of product platforms depending on customers’ specifications. This technology is supported by a substantial intellectual property portfolio that the Company has built through internal development and, to a lesser extent, acquisitions and license agreements.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font><font style="font-family:inherit;font-size:12pt;"> </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company’s stock options, goodwill valuation, deferred taxes and any associated valuation allowances, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, litigation costs and related accruals. Actual results could differ from such estimates.</font></div><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>

Files In Submission

Name	View Source	Status
0000937556-15-000155-index-headers.html	Edgar Link	pending
0000937556-15-000155-index.html	Edgar Link	pending
0000937556-15-000155.txt	Edgar Link	pending
0000937556-15-000155-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
masi-20151003.xml	Edgar Link	completed
masi-20151003.xsd	Edgar Link	pending
masi-20151003x10q.htm	Edgar Link	pending
masi-20151003x10qex121.htm	Edgar Link	pending
masi-20151003x10qex311.htm	Edgar Link	pending
masi-20151003x10qex312.htm	Edgar Link	pending
masi-20151003x10qex321.htm	Edgar Link	pending
masi-20151003_cal.xml	Edgar Link	unprocessable
masi-20151003_def.xml	Edgar Link	unprocessable
masi-20151003_lab.xml	Edgar Link	unprocessable
masi-20151003_pre.xml	Edgar Link	unprocessable
masimologo300q22015a01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MASI
MASIMO CORP Stock $masi

2015 Q4 Form 10-Q Financial Statement

#000093755615000155 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI MASIMO CORP Stock $masi

2015 Q4 Form 10-Q Financial Statement

#000093755615000155 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI
MASIMO CORP Stock $masi